<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03110666</url>
  </required_header>
  <id_info>
    <org_study_id>IOC-target</org_study_id>
    <nct_id>NCT03110666</nct_id>
  </id_info>
  <brief_title>Treatment for Knee Osteoarthritis With Injections of BMC at the Bone-cartilage Interface. Pilot Study</brief_title>
  <acronym>IOC-target</acronym>
  <official_title>Treatment for Knee Osteoarthritis With Injections of Autologous Concentrated Bone Marrow Aspirate at the Bone-cartilage Interface Via Percutaneous. Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istituto Ortopedico Rizzoli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istituto Ortopedico Rizzoli</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This pilot study will evaluate the clinica! and radiological results of a treatment for knee
      osteoarthritis with injections of autologous concentrated bone marrow aspirate at the
      bone-cartilage interface via percutaneous.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This pilot study (N=30) patients will evaluate the clinica! and radiological results of a
      treatment for knee osteoarthritis with injections of bone marrow concentrate (BMC),obtained
      from the Bone Marrow Aspirate Concentration System (BioCUE) at the bone-cartilage interface
      via percutaneous injections. The PerFuse system will also be evaluated to determine if it can
      be used to deliver the BMC to the osseous sites. Follow-up is 1, 3, 6, 12, and 24 months.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 25, 2016</start_date>
  <completion_date type="Anticipated">July 25, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 25, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>autologous concentrated bone marrow aspirate</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>improvement of the International Knee Documentation Committee (IKDC) subjective score</measure>
    <time_frame>Time Frame: 1,3,6, 12, 24 months evaluation</time_frame>
    <description>(International Knee Documentation Committee)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>improvement of the Knee Injury and osteoarthritis Outcome Score (KOOS)</measure>
    <time_frame>Time Frame: 1,3,6, 12, 24 months evaluation</time_frame>
    <description>(Knee Injury and osteoarthritis Outcome Score)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>evaluation of WORMS score for MRI</measure>
    <time_frame>Time Frame: 6, 12, 24 months evaluation</time_frame>
    <description>MRI score</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Knee Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Autologous concentrated bone marrow aspirate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>autologous concentrated bone marrow aspirate obtained from the BioCUE Concentration System</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Injection of autologous concentrated bone marrow aspirate</intervention_name>
    <description>Percutaneous injections at the bone-cartilage interface (distal femur and proximal tibia)</description>
    <arm_group_label>Autologous concentrated bone marrow aspirate</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age ranging from 40 to 75

          -  Osteoarthritis of the medial or lateral compartment (2-3-4 grade according to the
             Kellgren-Lawrence score);

          -  Failure after at least 6 months of conservative treatment (drug therapy with
             NSAIDs,hyaluronic acid,platelet-rich plasma and corticosteroids injections);

          -  Signature of informed consent.

        Exclusion Criteria:

          -  Patients with trauma in the 6 months prior to the intervention;

          -  Patients with malignancies;

          -  Patients with rheumatic diseases;

          -  Patients with diabetes;

          -  Patients suffering from metabolic disorders of the thyroid;

          -  Patients being abuse of alcohol, drugs or medications;

          -  Body Mass Index&gt; 35;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elizaveta Kon, MD</last_name>
    <role>Study Director</role>
    <affiliation>Rizzoli Orthopedic Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elizaveta Kon, MD</last_name>
    <phone>0516366567</phone>
    <email>e.kon@biomec.ior.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elizaveta Kon Kon, MD</last_name>
    <phone>0516336567</phone>
    <email>e.kon@biomec.ior.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Rizzoli Orthopaedic Institute</name>
      <address>
        <city>Bologna</city>
        <zip>40136</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizaveta Kon, MD</last_name>
      <phone>0516366567</phone>
      <email>e.kon@biomec.ior.it</email>
    </contact>
    <contact_backup>
      <last_name>Giuseppe Filardo, MD</last_name>
      <phone>0516366501</phone>
    </contact_backup>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 30, 2017</study_first_submitted>
  <study_first_submitted_qc>April 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2017</study_first_posted>
  <last_update_submitted>April 6, 2017</last_update_submitted>
  <last_update_submitted_qc>April 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istituto Ortopedico Rizzoli</investigator_affiliation>
    <investigator_full_name>Federica Balboni</investigator_full_name>
    <investigator_title>Sub-Investigator</investigator_title>
  </responsible_party>
  <keyword>knee osteoarthritis ,</keyword>
  <keyword>bone marrow aspirate</keyword>
  <keyword>injections</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

